Bausch Health Companies Future Growth
Future criteria checks 3/6
Bausch Health Companies is forecast to grow earnings and revenue by 218.3% and 1.5% per annum respectively while EPS is expected to grow by 222.8% per annum.
Key information
218.3%
Earnings growth rate
222.8%
EPS growth rate
Pharmaceuticals earnings growth | 21.3% |
Revenue growth rate | 1.5% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 02 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 10,249 | N/A | 2,860 | 1,280 | 5 |
12/31/2025 | 9,904 | 405 | 2,026 | 1,535 | 7 |
12/31/2024 | 9,573 | -55 | 650 | 1,287 | 7 |
9/30/2024 | 9,474 | -178 | 1,009 | 1,386 | N/A |
6/30/2024 | 9,202 | -471 | 911 | 1,263 | N/A |
3/31/2024 | 8,966 | -455 | 785 | 1,089 | N/A |
12/31/2023 | 8,757 | -592 | 760 | 1,032 | N/A |
9/30/2023 | 8,542 | -963 | 893 | 1,117 | N/A |
6/30/2023 | 8,350 | -186 | -665 | -428 | N/A |
3/31/2023 | 8,150 | -357 | -773 | -511 | N/A |
12/31/2022 | 8,124 | -225 | -996 | -728 | N/A |
9/30/2022 | 8,127 | 254 | -1,434 | -1,179 | N/A |
6/30/2022 | 8,192 | 43 | 384 | 648 | N/A |
3/31/2022 | 8,325 | -407 | 648 | 920 | N/A |
12/31/2021 | 8,434 | -948 | 1,143 | 1,426 | N/A |
9/30/2021 | 8,451 | -1,170 | 1,512 | 1,796 | N/A |
6/30/2021 | 8,478 | -1,287 | 1,190 | 1,488 | N/A |
3/31/2021 | 8,042 | -1,018 | 988 | 1,293 | N/A |
12/31/2020 | 8,027 | -560 | 802 | 1,111 | N/A |
9/30/2020 | 8,038 | -1,923 | 641 | 951 | N/A |
6/30/2020 | 8,109 | -2,043 | 899 | 1,210 | N/A |
3/31/2020 | 8,597 | -1,888 | 1,046 | 1,349 | N/A |
12/31/2019 | 8,601 | -1,788 | 1,223 | 1,501 | N/A |
9/30/2019 | 8,498 | -616 | 1,329 | 1,586 | N/A |
6/30/2019 | 8,425 | -917 | 1,386 | 1,593 | N/A |
3/31/2019 | 8,401 | -1,619 | 1,241 | 1,476 | N/A |
12/31/2018 | 8,380 | -4,148 | 1,266 | 1,501 | N/A |
9/30/2018 | 8,422 | -3,291 | 1,517 | 1,760 | N/A |
6/30/2018 | 8,505 | -1,640 | N/A | 1,728 | N/A |
3/31/2018 | 8,610 | -805 | N/A | 1,774 | N/A |
12/31/2017 | 8,724 | 2,404 | N/A | 2,290 | N/A |
9/30/2017 | 8,964 | 1,376 | N/A | 2,224 | N/A |
6/30/2017 | 9,224 | -1,143 | N/A | 2,304 | N/A |
3/31/2017 | 9,411 | -1,407 | N/A | 2,484 | N/A |
12/31/2016 | 9,674 | -2,409 | N/A | 2,087 | N/A |
9/30/2016 | 10,024 | -2,280 | N/A | 2,172 | N/A |
6/30/2016 | 10,332 | -1,013 | N/A | 2,360 | N/A |
3/31/2016 | 10,644 | -764 | N/A | 2,323 | N/A |
12/31/2015 | 10,442 | -292 | N/A | 2,257 | N/A |
9/30/2015 | 9,906 | 596 | N/A | 2,476 | N/A |
6/30/2015 | 9,175 | 822 | N/A | 2,336 | N/A |
3/31/2015 | 8,484 | 1,001 | N/A | 2,302 | N/A |
12/31/2014 | 8,200 | 881 | N/A | 2,312 | N/A |
9/30/2014 | 8,043 | 502 | N/A | 1,759 | N/A |
6/30/2014 | 7,529 | -746 | N/A | 1,342 | N/A |
3/31/2014 | 6,583 | -861 | N/A | 1,271 | N/A |
12/31/2013 | 5,766 | -866 | N/A | 1,042 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BVF is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: BVF is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BVF is expected to become profitable in the next 3 years.
Revenue vs Market: BVF's revenue (1.5% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: BVF's revenue (1.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BVF's Return on Equity is forecast to be high in 3 years time